論文 - 詳細
| RRC ID | 36972 |
|---|---|
| 著者 | Tomita O, Iijima K, Ishibashi T, Osumi T, Kobayashi K, Okita H, Saito M, Mori T, Shimizu T, Kiyokawa N. |
| タイトル | Sensitivity of SNX2-ABL1 toward tyrosine kinase inhibitors distinct from that of BCR-ABL1. |
| ジャーナル | Leuk Res |
| Abstract |
We introduced SNX2-ABL1, a novel ABL1-related chimeric transcript lacks SH3 and SH2 domains, into murine Ba/F3 cells and compared their function with that of BCR-ABL1. After the expression of SNX2-ABL1 proteins, Ba/F3 cells acquired an ability to proliferate in an IL-3-independent manner. Upon treatment with both imatinib and dasatinib, BCR-ABL1-expressing Ba/F3 cells underwent rapid apoptosis, whereas SNX2-ABL1-expressing Ba/F3 cells showed poorer sensitivity toward these TKIs and could proliferate in the presence of a low dose of dasatinib. Therefore, other TKIs with a more selective effect against this chimeric kinase should be used for the treatment of patients with SNX2-ABL1+ ALL. |
| 巻・号 | 38(3) |
| ページ | 361-70 |
| 公開日 | 2014-3-1 |
| DOI | 10.1016/j.leukres.2013.11.017 |
| PII | S0145-2126(13)00418-9 |
| PMID | 24367893 |
| MeSH | Animals B-Lymphocytes / drug effects* B-Lymphocytes / immunology B-Lymphocytes / pathology Benzamides / pharmacology Cell Line Dasatinib Dose-Response Relationship, Drug Drug Resistance, Neoplasm Fusion Proteins, bcr-abl / genetics* Fusion Proteins, bcr-abl / immunology Gene Expression Regulation, Leukemic / drug effects* Genetic Vectors Humans Imatinib Mesylate Interleukin-3 / pharmacology Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology Mice Piperazines / pharmacology Protein Kinase Inhibitors / pharmacology* Protein Structure, Tertiary Pyrimidines / pharmacology Retroviridae / genetics Sorting Nexins / genetics* Sorting Nexins / immunology Thiazoles / pharmacology Transfection |
| IF | 2.214 |
| 引用数 | 13 |
| WOS 分野 | ONCOLOGY HEMATOLOGY |
| オルトメトリクス指標 |
オルトメトリクス指標項目
|
| 最多言及媒体 | Patent(IFI CLAIMS) |
| 各媒体での言及数の合計 | 2 |
| 過去6か月間でのオルトメトリクス指標の変動値 | 0.0 |
| リソース情報 | |
| ヒト・動物細胞 | WEHI-3(RCB0035) |